Indicators | No CKD N = 935,947 | CKD by Risk of Progression to ESKD | |||
---|---|---|---|---|---|
Unknown n = 7344 | Low n = 23,037 | High n = 25,495 | |||
Diabetes (%) (2009/10–2011/12) | Prevalence | 7.02 (6.96–7.07) | 12.44 (8.64–17.92) | 28.59 (19.80–41.30) | 37.10 (25.62–53.73) |
Relative Risk | reference | 1.77 (1.23–2.55) | 4.08 (2.82–5.89) | 5.29 (3.65–7.66) | |
Hypertension (%) (2011/12) | Prevalence | 21.45 (21.36–21.55) | 31.06 (19.91–48.45) | 43.84 (28.01–68.61) | 61.46 (39.06–96.72) |
Relative Risk | reference | 1.45 (0.93–2.26) | 2.04 (1.31–3.20) | 2.87 (1.82–4.51) | |
Ischemic Heart Disease (%) (2007/08–2011/12) | Prevalence | 4.72 (4.68–4.77) | 7.30 (4.29–12.43) | 12.22 (7.20–20.74) | 24.55 (14.25–42.27) |
Relative Risk | reference | 1.55 (0.91–2.63) | 2.59 (1.52–4.39) | 5.20 (3.02–8.95) | |
Acute Myocardial Infarction (%) (2007/08–2011/12) | Prevalence | 0.99 (0.96–1.01) | 1.10 (0.63–1.93) | 2.29 (1.37–3.81) | 5.29 (3.12–8.97) |
Relative Risk | reference | 1.12 (0.64–1.96) | 2.32 (1.40–3.87) | 5.37 (3.16–9.11) | |
Congestive Heart Failure (%) (2009/10–2011/12) | Prevalence | 1.38 (1.35–1.41) | 4.51 (2.47–8.26) | 5.19 (2.88–9.35) | 25.09 (13.64–46.17) |
Relative Risk | reference | 3.27 (1.79–5.98) | 3.76 (2.09–6.77) | 18.17 (9.88–33.43) | |
Stroke (%) (2007/08–2011/12) | Prevalence | 0.41 (0.39–0.43) | 0.92 (0.51–1.67) | 2.01 (1.17–3.45) | 5.59 (3.13–9.98) |
Relative Risk | reference | 2.26 (1.25–4.10) | 4.94 (2.88–8.47) | 13.72 (7.68–24.50) | |
Atrial Fibrillation (%) (2009/10–2011/12) | Prevalence | 1.92 (1.89–1.94) | 3.09 (2.20–4.33) | 5.03 (3.64–6.94) | 9.72 (6.97–13.57) |
Relative Risk | reference | 1.61 (1.15–2.26) | 2.63 (1.90–3.63) | 5.08 (3.64–7.09) | |
Lower-Limb Amputation Among Diabetics (%) (2007/08–2011/12) | Prevalence | 0.33 (0.29–0.38) | 0.79 (0.44–1.42) | 0.77 (0.52–1.13) | 2.65 (1.83–3.84) |
Relative Risk | reference | 2.37 (1.32–4.27) | 2.30 (1.55–3.42) | 8.00 (5.53–11.57) |